乳腺癌抗雌激素药物耐药性基因1(BCAR1)重组蛋白

乳腺癌抗雌激素药物耐药性基因1(BCAR1)重组蛋白乳腺癌抗雌激素药物耐药性基因乳腺癌抗雌激素药物耐药性基因1(BCAR1)1(BCAR1)重组蛋白重组蛋白

Recombinant Breast Cancer Anti-Estrogen Resistance 1 (BCAR1)

Recombinant Breast Cancer Anti-Estrogen Resistance 1 (BCAR1)Recombinant Breast Cancer Anti-Estrogen Resistance 1 (BCAR1)Recombinant Breast Cancer Anti-Estrogen Resistance 1 (BCAR1)

CAS; CRKAS; P130Cas; CASS1; Crk-Associated Substrate; Cas Scaffolding Protein Family Member 1

CAS; CRKAS; P130Cas; CASS1; Crk-Associated Substrate; Cas Scaffolding Protein Family Member 1CAS; CRKAS; P130Cas; CASS1; Crk-Associated Substrate; Cas Scaffolding Protein Family Member 1CAS; CRKAS; P130Cas; CASS1; Crk-Associated Substrate; Cas Scaffolding Protein Family Member 1

---

·物种Homo sapiens (Human，人)

··物种物种物种Homo sapiens (HumanHomo sapiens (Human，人，人))

·来源原核表达

··来源来源来源原核表达原核表达

·宿主E.coli

··宿主宿主宿主E.coliE.coli

·内毒素水平<1.0EU/µg(LAL法测定)

··内毒素水平内毒素水平内毒素水平<1.0EU/µg(LAL<1.0EU/µg(LAL法测定法测定))

·亚细胞定位n/a

··亚细胞定位亚细胞定位亚细胞定位n/an/a

·预测分子量29.7kDa

··预测分子量预测分子量预测分子量29.7kDa29.7kDa

·实际分子量-(差异分析请参阅说明书)

··实际分子量实际分子量实际分子量-(-(差异分析请参阅说明书差异分析请参阅说明书))

·片段与标签Met1~Leu240 with N-terminal His Tag

··片段与标签片段与标签片段与标签Met1~Leu240 with N-terminal His TagMet1~Leu240 with N-terminal His Tag

·缓冲液成份磷酸盐缓冲液（pH7.4，含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）

··缓冲液成份缓冲液成份缓冲液成份磷酸盐缓冲液（磷酸盐缓冲液（pH7.4pH7.4，含有，含有 0.01% SKL, 1mM DTT, 5% Trehalose 0.01% SKL, 1mM DTT, 5% Trehalose和和Proclin300.Proclin300.））

·性状冻干粉

··性状性状性状冻干粉冻干粉

·纯度> 95%

··纯度纯度纯度> 95%> 95%

·等电点-

··等电点等电点等电点-

-


产品详情或技术咨询请联系客服QQ161303665或浏览官网www.shhebio.com 电话：021-57886085